- Positron Emission Tomography (PET) Scanner
- Single Photon Emission Computed Tomography (SPECT) Scanner
- Gamma Camera
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Magnetic Resonance Spectroscopy
- Optical Imaging
- Molecular Ultrasound Imaging
- Others
Molecular Imaging Market size is valued at USD 4,425.3 million in 2021 and is expected to reach a value of USD 6,437.4 million by 2028, growing at a CAGR of 5.5% during the forecast period 2022 to 2028. The global market provides a detailed overview of the market and that can be segmented by device type, application and end user. By device type, the molecular imaging market has been segmented into Positron Emission Tomography (PET) Scanner, Single Photon Emission Computed Tomography (SPECT) Scanner, Gamma Camera, Nuclear Magnetic Resonance (NMR) Spectrometer, Magnetic Resonance Spectroscopy, Optical Imaging, Molecular Ultrasound Imaging and Others. The Positron Emission Tomography (PET) Scanner segment is likely to be the largest and fastest-growing segment in terms of device type. Based on application, the molecular imaging market is segmented into cardiovascular, neurology, respiratory, oncology, gastrointestinal disorder and others. Among these, the cardiovascular segment is expected to have the fastest-growing market during the forecast period 2022-2028. On the basis of end users, the market is segregated into hospitals, ambulatory surgical centers, diagnostic imaging centers, and others. The hospitals held a considerable market share during the forecast period.
Molecular Imaging Market Summary
Study Period
2023-29
Base Year
2022
CAGR
5.5%
Largest Market
North America
Fastest Growing Market
Europe
Molecular Imaging Market Dynamics
Rising demand for accurate and reliable imaging systems for more accurate and detailed disease diagnosis, rising frequency of numerous chronic diseases, and ongoing development and innovation in molecular imaging technologies are some key factors fostering the market growth.
Molecular Imaging Market Regional Analysis
Asia-Pacific Got Significant Share
By region, the Asia Pacific market is expected to witness the highest market share during the forecast period. The prevalence of chronic diseases, urbanization, the aging population, and the need for better diagnostic treatment are all likely to contribute to the region's growth. North America held a considerable market share during the estimated period due to a surge in healthcare funding from public and commercial organizations for the creation of technologically sophisticated medical systems to meet the demands of a growing population suffering from various ailments.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Molecular Imaging Market Segmentation
Device Type
Application
- Cardiovascular,
- Neurology,
- Respiratory,
- Oncology,
- Gastrointestinal Disorder,
- Others
End-User
- Hospitals,
- Ambulatory Surgical Centers,
- Diagnostic Imaging Centers,
- Others
Frequently Asked Questions
The molecular imaging market is projected to expand at a CAGR of 5.5% during the forecast period.
The major players in the global molecular imaging market are Hitachi Medical Corporation (Japan), Siemens Healthineers (Germany), Toshiba Medical Systems (Japan), GE Healthcare (UK), Philips Healthcare (Netherlands), Esaote SpA (Italy), Sanrad Medical Systems Pvt. Ltd (India), Aurora Imaging Technology, Inc. (U.S.), SUMEC Group Corporation (China) and Positron Corporation (U.S.).
Asia Pacific is the fastest-growing region for molecular imaging market
| 1. Executive Summary |
| 2. Global Molecular Imaging Market Introduction |
| 2.1. Global Molecular Imaging Market – Taxonomy |
| 2.2. Global Molecular Imaging Market –Definitions |
| 2.2.1. Device Type |
| 2.2.2. Application |
| 2.2.3. End User |
| 3. Global Molecular Imaging Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Molecular Imaging Market Dynamic Factors - Impact Analysis |
| 3.6. Global Molecular Imaging Market – Competition Landscape |
| 3.7. Epidemiology |
| 4. Global Molecular Imaging Market Analysis,2017 - 2021 and Forecast, 2022 - 2028 |
| 4.1. Market Analysis,2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Molecular Imaging Market, By Device Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1. Positron Emission Tomography (PET) Scanner |
| 5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Single Photon Emission Computed Tomography (SPECT) Scanner |
| 5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Gamma Camera |
| 5.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Nuclear Magnetic Resonance (NMR) Spectrometer |
| 5.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Magnetic Resonance Spectroscopy |
| 5.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Optical Imaging |
| 5.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Molecular Ultrasound Imaging |
| 5.7.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Others |
| 5.8.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 6. Global Molecular Imaging Market Forecast, By Application, 2017 - 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
| 6.1. Cardiovascular |
| 6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Neurology |
| 6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Respiratory |
| 6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Oncology |
| 6.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Gastrointestinal Disorder |
| 6.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7. Global Molecular Imaging Market, By End User, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ambulatory Surgical Centers |
| 7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Diagnostic Imaging Centers |
| 7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Molecular Imaging Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Molecular Imaging Market - Opportunity Analysis Index, By Technology, Device Type, Application and Region, 2022 - 2028 |
| 9. North America Molecular Imaging Market Analysis,2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 9.1. Device Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.1.1. Positron Emission Tomography (PET) Scanner |
| 9.1.2. Single Photon Emission Computed Tomography (SPECT) Scanner |
| 9.1.3. Gamma Camera |
| 9.1.4. Nuclear Magnetic Resonance (NMR) Spectrometer |
| 9.1.5. Magnetic Resonance Spectroscopy |
| 9.1.6. Optical Imaging |
| 9.1.7. Molecular Ultrasound Imaging |
| 9.1.8. Others |
| 9.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Cardiovascular |
| 9.2.2. Neurology |
| 9.2.3. Respiratory |
| 9.2.4. Oncology |
| 9.2.5. Gastrointestinal Disorder |
| 9.2.6. Others |
| 9.3. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Hospitals |
| 9.3.2. Ambulatory Surgical Centers |
| 9.3.3. Diagnostic Imaging Centers |
| 9.3.4. Others |
| 9.4. Country Analysis 2017 - 2021 and Forecast 2022 - 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. USA |
| 9.4.2. Canada |
| 9.5. North America Molecular Imaging Market - Opportunity Analysis Index, By  Device Type, Application, End User and Country, 2022 - 2028 |
| 9.6. North America Molecular Imaging Market Dynamics – Trends |
| 10. Europe Molecular Imaging Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 10.1. Device Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.1.1. Positron Emission Tomography (PET) Scanner |
| 10.1.2. Single Photon Emission Computed Tomography (SPECT) Scanner |
| 10.1.3. Gamma Camera |
| 10.1.4. Nuclear Magnetic Resonance (NMR) Spectrometer |
| 10.1.5. Magnetic Resonance Spectroscopy |
| 10.1.6. Optical Imaging |
| 10.1.7. Molecular Ultrasound Imaging |
| 10.1.8. Others |
| 10.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Cardiovascular |
| 10.2.2. Neurology |
| 10.2.3. Respiratory |
| 10.2.4. Oncology |
| 10.2.5. Gastrointestinal Disorder |
| 10.2.6. Others |
| 10.3. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Hospitals |
| 10.3.2. Ambulatory Surgical Centers |
| 10.3.3. Diagnostic Imaging Centers |
| 10.3.4. Others |
| 10.4. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Russia |
| 10.4.7. Poland |
| 10.4.8. Rest of Europe |
| 10.5. Europe Molecular Imaging Market - Opportunity Analysis Index, By  Device Type, Application, End User and Country, 2022 - 2028 |
| 10.6. Europe Molecular Imaging Market Dynamics – Trends |
| 11. Asia-Pacific Molecular Imaging Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 11.1. Device Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.1.1. Positron Emission Tomography (PET) Scanner |
| 11.1.2. Single Photon Emission Computed Tomography (SPECT) Scanner |
| 11.1.3. Gamma Camera |
| 11.1.4. Nuclear Magnetic Resonance (NMR) Spectrometer |
| 11.1.5. Magnetic Resonance Spectroscopy |
| 11.1.6. Optical Imaging |
| 11.1.7. Molecular Ultrasound Imaging |
| 11.1.8. Others |
| 11.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Cardiovascular |
| 11.2.2. Neurology |
| 11.2.3. Respiratory |
| 11.2.4. Oncology |
| 11.2.5. Gastrointestinal Disorder |
| 11.2.6. Others |
| 11.3. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Hospitals |
| 11.3.2. Ambulatory Surgical Centers |
| 11.3.3. Diagnostic Imaging Centers |
| 11.3.4. Others |
| 11.4. Country Analysis2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Japan |
| 11.4.2. China |
| 11.4.3. India |
| 11.4.4. ASEAN |
| 11.4.5. Australia & New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Molecular Imaging Market - Opportunity Analysis Index, By  Device Type, Application, End User and Country, 2022 - 2028 |
| 11.6. Asia-Pacific Molecular Imaging Market Dynamics – Trends |
| 12. Latin America Molecular Imaging Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 12.1. Device Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.1.1. Positron Emission Tomography (PET) Scanner |
| 12.1.2. Single Photon Emission Computed Tomography (SPECT) Scanner |
| 12.1.3. Gamma Camera |
| 12.1.4. Nuclear Magnetic Resonance (NMR) Spectrometer |
| 12.1.5. Magnetic Resonance Spectroscopy |
| 12.1.6. Optical Imaging |
| 12.1.7. Molecular Ultrasound Imaging |
| 12.1.8. Others |
| 12.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Cardiovascular |
| 12.2.2. Neurology |
| 12.2.3. Respiratory |
| 12.2.4. Oncology |
| 12.2.5. Gastrointestinal Disorder |
| 12.2.6. Others |
| 12.3. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Hospitals |
| 12.3.2. Ambulatory Surgical Centers |
| 12.3.3. Diagnostic Imaging Centers |
| 12.3.4. Others |
| 12.4. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Argentina |
| 12.4.4. Rest of Latin America |
| 12.5. Latin America Molecular Imaging Market - Opportunity Analysis Index, By  Device Type, Application, End User and Country, 2022 - 2028 |
| 12.6. Latin America Molecular Imaging Market Dynamics – Trends |
| 13. Middle East and Africa Molecular Imaging Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 13.1. Device Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.1.1. Positron Emission Tomography (PET) Scanner |
| 13.1.2. Single Photon Emission Computed Tomography (SPECT) Scanner |
| 13.1.3. Gamma Camera |
| 13.1.4. Nuclear Magnetic Resonance (NMR) Spectrometer |
| 13.1.5. Magnetic Resonance Spectroscopy |
| 13.1.6. Optical Imaging |
| 13.1.7. Molecular Ultrasound Imaging |
| 13.1.8. Others |
| 13.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Cardiovascular |
| 13.2.2. Neurology |
| 13.2.3. Respiratory |
| 13.2.4. Oncology |
| 13.2.5. Gastrointestinal Disorder |
| 13.2.6. Others |
| 13.3. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Hospitals |
| 13.3.2. Ambulatory Surgical Centers |
| 13.3.3. Diagnostic Imaging Centers |
| 13.3.4. Others |
| 13.4. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. Israel |
| 13.4.3. South Africa |
| 13.4.4. Rest of MEA |
| 13.5. MEA Molecular Imaging Market - Opportunity Analysis Index, By  Device Type, Application, End User and Country, 2022 - 2028 |
| 13.6. MEA Molecular Imaging Market Dynamics – Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Device Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Bruker Corporation |
| 14.2.2. Carestream Health, Inc. |
| 14.2.3. GE Company |
| 14.2.4. Hamamatsu Photonics |
| 14.2.5. Hermes Medical Solutions |
| 14.2.6. Koninklijke Philips N.V. |
| 14.2.7. Medisco Ltd. |
| 14.2.8. MIM Software Inc. |
| 14.2.9. Mirada Medical Limited |
| 14.2.10. Perkin-Elmer |
| 14.2.11. Positron Corporation |
| 14.2.12. Siemens Healthcare GmbH |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
- Hitachi Medical Corporation (Japan)
- Siemens Healthineers (Germany)
- Toshiba Medical Systems (Japan)
- GE Healthcare (UK)
- Philips Healthcare (Netherlands)
- Esaote SpA (Italy)
- Sanrad Medical Systems Pvt. Ltd (India)
- Aurora Imaging Technology, Inc. (U.S.)
- SUMEC Group Corporation (China)
- Positron Corporation (U.S.)